Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide (Q57607827)
Jump to navigation
Jump to search
article by Nathan R. Martinez et al published 1 May 2003 in Journal of Clinical Investigation
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide |
article by Nathan R. Martinez et al published 1 May 2003 in Journal of Clinical Investigation |
Statements
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide (English)
0 references
1 May 2003
0 references
111
0 references
1365-1371
0 references
9
0 references